TechLife Capital
Overview
TechLife Capital is a growth private equity fund specializing in the healthcare and technology industries, registered with the French Autorité des Marchés Financiers. The firm targets profitable companies with a proven business model and ambitions for international expansion, with equity commitments typically ranging from €5 million to €50 million.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Mitem Pharma | Sep 2024 | Corporate Funding | Co-investor |
| Ad Scientiam | Nov 2023 | VC Round | Lead |
| Quinten Health | Sep 2022 | Growth Equity | Co-investor |
For institutional investors. Book with your work email.
Key People
Jacques Rossignol
Managing Partner in Healthcare & Technology Private Equity
DELPHINE PICOTIN
Operating Partner
Stanislas de Bentzmann
Operating Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is TechLife Capital based?
TechLife Capital is headquartered in Paris, France.
When was TechLife Capital founded?
TechLife Capital was founded in 2018.
How many portfolio companies does TechLife Capital have?
TechLife Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in TechLife Capital's portfolio?
Portfolio companies visible on Caplight include Mitem Pharma, Ad Scientiam, Quinten Health.
What was TechLife Capital's most recent investment shown here?
TechLife Capital's most recent investment in this portfolio sample was in Mitem Pharma in 2024.
What sectors does TechLife Capital focus on?
TechLife Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does TechLife Capital focus on?
TechLife Capital typically invests at the Late stage.